Floatz logo

142 assets in Schizophrenia

Therapeutic assets addressing Schizophrenia, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
hs-10380
Schizophrenia
Jiangsu Hansoh Pharmaceutical Co., Ltd.P2B (59)
Karxt
Schizophrenia
Karuna Therapeutics, Inc., a Bristol Myers Squibb companyP3B (59)
tv-44749
Schizophrenia
Teva Branded Pharmaceutical Products R&D LLCP3B (59)
Aspirin
Schizophrenia
Hôpital le VinatierP3B (58)
Elpipodect
Schizophrenia
Merck Sharp & Dohme LLCP2B (58)
Pimavanserin
Schizophrenia
Bjorn H. EbdrupP3B (58)
Cogentin
Schizophrenia
University of PittsburghP4B (57)
Mitoquinol Mesilate
Schizophrenia
Mclean HospitalP2/3B (57)
2-Bromo-?-ergocryptine
Schizophrenia
VA Pittsburgh Healthcare SystemP4B (56)
Bazedoxifene
Schizophrenia
The AlfredP4B (56)
il-23
Schizophrenia
University of Maryland, BaltimoreP4B (56)
Nbi-1117568
Schizophrenia
Neurocrine BiosciencesP3B (56)
Samidorphan
Schizophrenia
Alkermes, Inc.P3B (56)
Buspirone
Schizophrenia
Chuanfu SongP3CCC (54)
Infliximab
Schizophrenia
Emory UniversityP4CCC (54)
Paroxetine
Schizophrenia
Dr. Inge WinterP3CCC (54)
Fruquintinib
Schizophrenia
Meng QiuP2CCC (53)
Raltitrexed
Schizophrenia
Meng QiuP2CCC (53)
S-1
Schizophrenia
Meng QiuP2CCC (53)
Tirzepatide
Schizophrenia
Anders Fink-Jensen, MD, DMSciP2CCC (53)
Trastuzumab
Schizophrenia
Aiping ZhouP2CCC (53)
Atorvastatin
Schizophrenia
Central South UniversityP3CCC (52)
ly03020
Schizophrenia
Luye Pharma Group Ltd.P2CCC (52)
Moxifloxacin
Schizophrenia
Merck Sharp & Dohme LLCP1CCC (52)
Oxaliplatin
Schizophrenia
Aiping ZhouP2CCC (52)
Tiagabine
Schizophrenia
Beth Israel Deaconess Medical CenterP3CCC (52)
VENLOR
Schizophrenia
Dr. Inge WinterP3CCC (52)
Benzoic Acid
Schizophrenia
National Cheng-Kung University HospitalP2CCC (51)
Luvadaxistat
Schizophrenia
Neurocrine BiosciencesP2CCC (51)
jx11502ma
Schizophrenia
Zhejiang Jingxin Pharmaceutical Co., Ltd.P1/2CCC (49)
1-(2,8-DIMETHYL-1-THIA-3,8-DIAZASPIRO(4.5)DEC-3-YL)-3-(1H-INDOL-3-YL)PROPAN-1-ONE
Schizophrenia
Anavex Life Sciences Corp.P2CCC (48)
Alto-101
Schizophrenia
Alto NeuroscienceP2CCC (48)
br5402a
Schizophrenia
Boryung Pharmaceutical Co., LtdP2CCC (48)
BR5402A-1
Schizophrenia
Boryung Pharmaceutical Co., LtdP2CCC (48)
br5402b
Schizophrenia
Boryung Pharmaceutical Co., LtdP2CCC (48)
BR5402B-1
Schizophrenia
Boryung Pharmaceutical Co., LtdP2CCC (48)
br5402c
Schizophrenia
Boryung Pharmaceutical Co., LtdP2CCC (48)
br5402c-1
Schizophrenia
Boryung Pharmaceutical Co., LtdP2CCC (48)
br5402d
Schizophrenia
Boryung Pharmaceutical Co., LtdP2CCC (48)
br5402d-1
Schizophrenia
Boryung Pharmaceutical Co., LtdP2CCC (48)
Brenipatide
Schizophrenia
Eli Lilly and CompanyP2CCC (48)
Bromazepam
Schizophrenia
Rakitzi, StavroulaP3CCC (48)
Buprenorphine
Schizophrenia
University of California, Los AngelesP2CCC (48)
Clemastin
Schizophrenia
LMU KlinikumP2CCC (48)
Dasatinib
Schizophrenia
Washington University School of MedicineP2CCC (48)
Dextrose
Schizophrenia
Beth Israel Deaconess Medical CenterP2CCC (48)
Flavone, 3,3',4',5,7-Pentahydroxy-
Schizophrenia
Washington University School of MedicineP2CCC (48)
gxv813
Schizophrenia
Novartis PharmaceuticalsP2CCC (48)
ly03010
Schizophrenia
Luye Pharma Group Ltd.P1CCC (48)
Nbi-1117570
Schizophrenia
Neurocrine BiosciencesP2CCC (48)
Showing 51 to 100 of 142 assets
PreviousPage 2 of 3Next